c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies

Jochem H. Bernink,Yoichiro Ohne,Marcel B. M. Teunissen,Jingya Wang,Jincheng Wu,Lisette Krabbendam,Christine Guntermann,Richard Volckmann,Jan Koster,Sophie van Tol,Ivan Ramirez,Yashaswi Shrestha,Menno A. de Rie,Hergen Spits,Xavier Romero Ros,Alison A. Humbles
DOI: https://doi.org/10.1038/s41590-019-0423-0
IF: 30.5
2019-07-01
Nature Immunology
Abstract:Here we identify a group 2 innate lymphoid cell (ILC2) subpopulation that can convert into interleukin-17 (IL-17)-producing NKp44<sup>−</sup> ILC3-like cells. c-Kit and CCR6 define this ILC2 subpopulation that exhibits ILC3 features, including RORγt, enabling the conversion into IL-17-producing cells in response to IL-1β and IL-23. We also report a role for transforming growth factor-β in promoting the conversion of c-Kit<sup>−</sup> ILC2s into RORγt-expressing cells by inducing the upregulation of <i>IL23R</i>, <i>CCR6</i> and <i>KIT</i> messenger RNA in these cells. This switch was dependent on RORγt and the downregulation of GATA-3. IL-4 was able to reverse this event, supporting a role for this cytokine in maintaining ILC2 identity. Notably, this plasticity has physiological relevance because a subset of RORγt<sup>+</sup> ILC2s express the skin-homing receptor CCR10, and the frequencies of IL-17-producing ILC3s are increased at the expense of ILC2s within the lesional skin of patients with psoriasis.
immunology
What problem does this paper attempt to address?